🔴 Telix Pharmaceuticals is trading 4.04% down with no confirmed explanation

Telix Pharmaceuticals is trading 4.04% lower at A$14.98 on October 2, 2026; no company announcement clearly explains the decline.

• The provided price context shows a 0.70% decline in the October 1 close.
• FDA Fast Track news for BiPASS was announced September 29 and is prior context, not a confirmed cause.
• Broader Australian market weakness was reported October 1, but evidence does not establish it as the driver. No trading volume is provided.